{"title":"Opill (norgestrel): Where does the OTC birth control pill fit in among existing contraception?","authors":"Nicole Daher, Jolene Bohensky","doi":"10.1097/01.JAA.0000000000000209","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Oral contraceptive pills have been a cornerstone of contraception for more than 6 decades. Oral contraceptives are highly effective in preventing unintended pregnancy, making them the most utilized reversible contraceptive method. Daily oral contraceptive pills have traditionally required a prescription from a healthcare provider due to potential risks and adverse reactions associated with use. The need for prescription creates significant barriers to accessibility and convenience for patients who may resort to less effective but more readily available nonprescription methods. Opill® (norgestrel) is the first and only FDA-approved daily oral contraceptive for over-the-counter use. This article examines Opill's place in the current US contraceptive market.</p>","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":"38 6","pages":"11-13"},"PeriodicalIF":0.8000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jaapa-Journal of the American Academy of Physician Assistants","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/01.JAA.0000000000000209","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract: Oral contraceptive pills have been a cornerstone of contraception for more than 6 decades. Oral contraceptives are highly effective in preventing unintended pregnancy, making them the most utilized reversible contraceptive method. Daily oral contraceptive pills have traditionally required a prescription from a healthcare provider due to potential risks and adverse reactions associated with use. The need for prescription creates significant barriers to accessibility and convenience for patients who may resort to less effective but more readily available nonprescription methods. Opill® (norgestrel) is the first and only FDA-approved daily oral contraceptive for over-the-counter use. This article examines Opill's place in the current US contraceptive market.
期刊介绍:
JAAPA is the peer-reviewed clinical journal of the American Academy of Physician Assistants (AAPA). Published for more than 25 years, its mission is to support the ongoing education and advancement of physician assistants (PAs) by publishing current information and research on clinical, health policy, and professional issues.
Published monthly, JAAPA''s award-winning editorial includes:
-Clinical review articles (with AAPA-approved Category I CME in each issue)-
Case reports-
Clinical departments-
Original health services research-
Articles on issues of professional interest to PAs